1-3 of 3
vascular access complications
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1b/2 Study of Chidamide Combined with CHOP in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL)

Yuankai Shi, MD, Lin Gui, MD, Junning Cao, MD, Huilai Zhang, MD, Jun Zhu, MD PhD, Dongmei Ji, MD PhD, Qian Fan, MD, Yuqin Song, MD PhD, Weina Shen, MM, Guiying Bai, MM, Ming-Zhe Han, MD, Shiyu Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2840.
https://doi.org/10.1182/blood-2019-128078
Published: 2019
Journal Articles

Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study

Grzegorz S. Nowakowski, MD, Betsy R. LaPlant, Craig Reeder, MD, James M. Foran, MD, FRCPC, Luis F. Porrata, MD, William R Macon, MD, Patrick B. Johnston, MD, PhD, Candido E. Rivera, MD, Thomas M Habermann, MD, David J. Inwards, MD, Ivana N. Micallef, MD, Garth D Nelson, Stephen M. Ansell, M.D., Ph.D., Thomas E. Witzig, MD
Journal: Blood
Blood (2012) 120 (21): 689.
https://doi.org/10.1182/blood.V120.21.689.689
Published: 2012
Journal Articles

High Prevalence of Antibodies to the Heparin-Platelet Factor 4 Complex in Hemodialysis Patients.

Marc Carrier, MD, Greg Knoll, MD, Michael Kovacs, MD, Marc A. Rodger, MD
Journal: Blood
Blood (2005) 106 (11): 4119.
https://doi.org/10.1182/blood.V106.11.4119.4119
Published: 2005